1-27356738-CCTT-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PM4_SupportingBP6_ModerateBS2
The NM_004672.5(MAP3K6):c.3373_3375delAAG(p.Lys1125del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,565,996 control chromosomes in the GnomAD database, including 130 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0081 ( 7 hom., cov: 33)
Exomes 𝑓: 0.011 ( 123 hom. )
Consequence
MAP3K6
NM_004672.5 conservative_inframe_deletion
NM_004672.5 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.219
Genes affected
MAP3K6 (HGNC:6858): (mitogen-activated protein kinase kinase kinase 6) This gene encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_004672.5. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 1-27356738-CCTT-C is Benign according to our data. Variant chr1-27356738-CCTT-C is described in ClinVar as [Benign]. Clinvar id is 2638557.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 1229 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K6 | NM_004672.5 | c.3373_3375delAAG | p.Lys1125del | conservative_inframe_deletion | 25/29 | ENST00000357582.3 | NP_004663.3 | |
MAP3K6 | NM_001297609.2 | c.3349_3351delAAG | p.Lys1117del | conservative_inframe_deletion | 24/28 | NP_001284538.1 | ||
MAP3K6 | XM_047433689.1 | c.3280_3282delAAG | p.Lys1094del | conservative_inframe_deletion | 26/30 | XP_047289645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K6 | ENST00000357582.3 | c.3373_3375delAAG | p.Lys1125del | conservative_inframe_deletion | 25/29 | 1 | NM_004672.5 | ENSP00000350195.2 |
Frequencies
GnomAD3 genomes AF: 0.00807 AC: 1229AN: 152212Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
1229
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00763 AC: 1596AN: 209300Hom.: 8 AF XY: 0.00799 AC XY: 893AN XY: 111802
GnomAD3 exomes
AF:
AC:
1596
AN:
209300
Hom.:
AF XY:
AC XY:
893
AN XY:
111802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0112 AC: 15821AN: 1413666Hom.: 123 AF XY: 0.0110 AC XY: 7703AN XY: 698468
GnomAD4 exome
AF:
AC:
15821
AN:
1413666
Hom.:
AF XY:
AC XY:
7703
AN XY:
698468
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00807 AC: 1229AN: 152330Hom.: 7 Cov.: 33 AF XY: 0.00772 AC XY: 575AN XY: 74484
GnomAD4 genome
AF:
AC:
1229
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
575
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | MAP3K6: PM4:Supporting, BS1, BS2 - |
MAP3K6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at